MAT1A and metabolic dysfunction-associated steatotic liver disease: Most of differentially methylated CpG sites were hypomethylated in obese patients with advanced vs mild NAFLD. Methylation at FGFR2, MAT1A and CASP1 was validated in a replication cohort.